Back to News
Market Impact: 0.2
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
Source: businesswire.com
Legal & LitigationHealthcare & Biotech
Hagens Berman is investigating claims in a class-action complaint brought by investors against PROCEPT BioRobotics (PRCT). The notice provides no allegations, damages figures, operating impact, or financial results, but introduces litigation risk for the medical-device company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
PRCT-0.85
More News
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Jefferies raises West Pharmaceutical stock price target on HVP growth
- People Inc earnings up next after MGM deal collapse
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Wells Fargo raises Regeneron stock price target to $925 on execution